OA14.01 KEYNOTE-024 3-Year Survival Update: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer

Authors :: Maya Gottfried
Shruti Rao
Martin Reck
Sinead Cuffe
Katsuyuki Hotta
Erin Jensen
Delvys Rodriguez-Abreu
Andrew G. Robinson
Tibor Csőszi
T. Garay
Rina Hui
Julie R. Brahmer
Nir Peled
Victoria Ebiana
Andrea Fülöp
Mary O'Brien
Ali Tafreshi
Source :: Journal of Thoracic Oncology. 14:S243
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
Chemotherapy
medicine.medical_specialty
business.industry
medicine.medical_treatment
Pembrolizumab
medicine.disease
Internal medicine
Medicine
Non small cell
business
Lung cancer

Tools